Revista de Ciencias de la Salud
25. Campagna S, Mathot AG, Fleury Y, Girardet JM, Gaillard JL. Antibacterial activity of
lactophoricin, a synthetic 23-residues peptide derived from the sequence of bovine milk
component-3 of proteose peptone. J Dairy Sci. 2004; 87(6):1621-6.
26. Schack L, Lange A, Kelsen J, Agnholt J, Christensen B, Petersen TE et al. Considerable
variation in the concentration of osteopontin in human milk, bovine milk, and infant formulas.
J Dairy Sci. 2009; 92(11):5378-85.
27. Weber GF, Zawaideh S, Hikita S, Kumar VA, Cantor H, Ashkar S.J. Phosphorylation-
dependent interaction of osteopontin with its receptors regulates macrophage migration and
activation. Leukoc Biol. 2002; 72(4):752-61.
28. Pang H, Lu H, Song H, Meng Q, Zhao Y, Liu N et al. Prognostic values of osteopontin-c, E-
cadherin and β-catenin in breast cancer. Cancer Epidemiol. 2013; 37(6):985-92.
29. Bramwell VH, Tuck AB, Chapman JA, Anborgh PH, Postenka CO, Al-Katib W et al.
Assessment of osteopontin in early breast cancer: correlative study in a randomised clinical
trial. Breast Cancer Res. 2001; 16(1):R8.
30. Ramchandani D, Weber GF. An osteopontin promoter polymorphism is associated with
aggressiveness in breast cancer. Oncol Rep. 2013; 30(4):1860-8.
31. Holt C, Sørensen ES, Clegg RA. Role of calcium phosphate nanoclusters in the control of
calcification. FEBS J. 2009; 276(8):2308-23.
32. Standal T, Borset M, Sundan A. Role of osteopontin in adhesion, migration, cell survival and
bone remodeling. Exp Oncol. 2004; 26(3):179-84.
33. Gericke A, Qin C, Spevak L, Fujimoto Y, Butler WT, Sørensen ES, Boskey AL. Importance
of Phosphorylation for Osteopontin Regulation of Biomineralization. Calcif Tissue Int. 2005;
77(1): 45–54.
34. Pampena DA, Robertson KA, Litvinova O, Lajoie G, Goldberg HA, Hunter GK. Inhibition of
hydroxyapatite formation by osteopontin phosphopeptides. Biochem J. 2004; 378(Pt
3):1083-7.
35. Agnholt J1, Kelsen J, Schack L, Hvas CL, Dahlerup JF, Sørensen ES. Osteopontin, a
protein with cytokine-like properties, is associated with inflammation in Crohn's disease.
Scand J Immunol. 2007; 65(5):453-60.
36. Pepe G, Tenore GC, Mastrocinque R, Stusio P, Campiglia P. Potential Anticarcinogenic
Peptides from Bovine Milk. J Amino Acids. 2013; 2013:939804.
37. Le Maux S, Bouhallab S, Giblin L, Brodkorb A, Croguennec T. Bovine β-lactoglobulin/fatty
acid complexes: binding, structural, and biological properties. Dairy Sci Technol. 2014;
94:409-426.
38. Kontopidis G, Holt C, Sawyer L. The ligand-binding site of bovine beta-lactoglobulin:
evidence for a function? J Mol Biol. 2002; 318(4):1043-55
39. Kontopidis G, Holt C, Sawyer L. Invited review: beta-lactoglobulin: binding properties,
structure, and function. J Dairy Sci. 2004; 87(4):785-96.
40. Guimont C, Marchall E, Girardet JM, Linden G. Biologically active factors in bovine milk and
dairy byproducts: influence on cell culture. Crit Rev Food Sci Nutr 1997; 37:393-410.
41. Sahihi M, Ghayeb Y. An investigation of molecular dynamics simulation and molecular
docking: interaction of citrus flavonoids and bovine β-lactoglobulin in focus. Comput Biol
Med. 2014; 51:44-50.
42. Mensi A, Borel P, Goncalves A, Nowicki M, Gleize B, Roi S, Chobert JM, Haertlé T, Reboul
E. β-lactoglobulin as a vector for β-carotene food fortification. J Agric Food Chem. 2014;
62(25):5916-24.
43. Heine W.E., Klein P.D., Reeds P.J.: The importance of alpha-lactalbumin in infant nutrition.
J Nutr. 1991; 121: 277-283
44. Teschemacher H, Koch G. Opioids in the milk. Endocr Regul. 1991;25(3):147-50.
Qhalikay. Revista de Ciencias de la Salud 3 (2017) 121-132
130